ALIMP — Implanet SA Share News
0.000.00%
Last trade - 00:00- €21.42m
- €25.87m
- €12.47m
French and Benelux stocks-Factors to watch on September 16
France's IMPLANET H1 revenue rises on medical equipment strength, US growth
Brief: IMPLANET H1 Revenue EUR 7.1 Million
France's IMPLANET H1 revenue rises on spine implants strength, US growth
France's IMPLANET Q1 revenue rises as U.S. medical equipment business expands
France's IMPLANET FY25 revenue up 33% on higher exports
Brief: IMPLANET FY Operating Income EUR -4.22 Million
France's IMPLANET 2025 revenue rises
Brief: IMPLANET H1 Operating Income EUR -2.14 Million
Brief: Implanet Announces CFDA Approval For Its Innovative Jazz Range In China
Brief: IMPLANET H1 Operating Income EUR -2.32 Million
Brief: IMPLANET FY Net Income at EUR -6.7 Million
Brief: Shanghai Sanyou Medical To Boost Holdings In Implanet SA
Brief: Implanet Finalizes Agreement To Acquire OSD
Brief: Implanet 2020 Revenue At EUR 6 Mln
Brief: Implanet And Seaspine Announce FDA Clearance Of Mariner Cap System
Brief: Implanet Q3 Revenue Stable At 1.75 Million Euros
Brief: Implanet H1 Net Loss At 2.41 Million Euros
Brief: Implanet Q2 Revenue Down At EUR 1.03 Million